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Abstract 
The objective of this study was to design citrate-coated gold nanoparticles conjugated 
with FITC-IgG, a fluorescent antibody, and to qualitatively and quantitatively measure the 
resulting fluorescent emission. Optical properties of the gold nanoparticles were measured at 
various stages to provide evidence of successful conjugation. The absorbance spectrum of the 
citrate gold nanoparticles was compared to that of the reaction mixture containing the gold 
nanoparticles and the FITC-IgG. A noticeable broadening of the absorption peak was observed at 
519 nm indicating a surface modification of the gold nanoparticles. Fluorescence data was 
obtained with a fluorospectrometer and revealed a significant amount of fluorescent quenching in 
the reaction mixture as well as the washed mixture containing only fully conjugated molecules. 
However, the conjugated nanoparticles still emitted fluorescence at 519 nm as shown by the 
images captured under confocal microscopy. Based on the obtained optical densities of the 
reaction mixture and the FITC-IgG, the mass of molecules that were conjugated to the 
nanoparticles was calculated and determined to be approximately 24 FITC-IgG molecules per 
gold nanoparticle.  
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Introduction 
 Nanotechnology is an applied science involving particles on the scale of 1-100 nm in 
diameter. Advancements in the field of nanotechnology have proven to be applicable in the fields 
of computer engineering, physics, and of particular interest medicine. In 2007, nearly $60 billion 
worth of nanotechnology-based products were sold3. Currently in 2016, these figures have 
exceeded $1 trillion. However, at this stage nanotechnology is still in its infancy as its potential 
exceeds its products.  
 Nanomedicine has become one of the main fields of research involving nanotechnology. 
It has the potential to develop new methods of diagnosing, preventing and treating various 
diseases. Many of these applications stem from the fact that nanoparticles such as those made of 
silver (Ag) and gold (Au) are unique due to their size on the nanoscale. Electrons in the 
conduction band tend to oscillate at some extinction peak when light of a wavelength comparable 
in size to the nanoparticle is incident as shown in Figure 1. This is called localized surface 
plasmon resonance (LSPR). As a result of the LSPR phenomenon, a resonant field surrounds the 
nanoparticle getting stronger as the distance from the surface decreases. Thus, being smaller than 
the wavelength of light allows nanoparticles to exhibit unique physical and optical properties.4  
 
Figure 1: Localized surface plasmon produced by interaction between the free electrons in the particles and an incident 
electromagnetic wave. [9] 
Gold nanoparticles have several properties that make them promising agents for stem cell 
labeling and tracking. They are easy to manufacture and conjugate to a wide variety of 
biomolecular targets5. Furthermore, In vitro studies have shown that mesenchymal and adipose-
derived stem cells labeled with gold nanoparticles did not demonstrate changes in cell function 
or proliferation, and no toxicity was apparent. The binding of gold nanoparticles to stem cells 
requires the expression of an antibody specific to a protein that is characterized on the surface of 
the stem cell of interest. This can be accomplished by conjugating antibodies to gold 
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nanoparticles through various binding mechanism. The nanoparticle is first coated with citrate, a 
stabilizing agent. This negatively charged coating prevents the nanoparticles from aggregating in 
solution. The first binding mechanism is via hydrophobic interactions. Hydrophobic parts of the 
antibodies become attracted to the surface of the nanoparticle forming a non-covalent bond. The 
second binding mechanism is through electrostatic interactions of positively charged amino acids 
on the antibodies and the negatively charged citrate coating. The last mechanism is through 
covalent bonds between the nanoparticle and free sulfhydryl groups of the antibody. As a result, 
controlling the directionality of the antibodies would require new conditions for binding. The 
mechanisms described are shown respectively in the schematic in Figure 211.  
 
Figure 2. A Schematic diagram of possible orientations of antibodies on AuNPs. 
Once bound, nanoparticles can be further engineered for potential use as a stem cell 
delivery system to areas of the body that require cell/tissue regeneration. One such application is 
in the regeneration of ischemic cardiac tissue after an acute myocardial infarction (AMI). In the 
United States, cardiovascular disease is the leading cause of death in the United Sates, claiming 
more lives than all forms of cancer combined1. Of the various forms of heart disease, coronary 
artery disease (CAD) is the most common, eventually leading to AMI. Every year approximately 
735,000 Americans suffer from AMI1.  Atherosclerosis, the buildup of plaque (fat, cholesterol, 
and other substances) in the coronary arteries, causes the blood vessels to narrow and ultimately 
restricts the flow of blood to the myocardium.  
As blood flow is interrupted in an AMI, cardiomyocytes begin to die because they are 
unable to obtain oxygen and the necessary nutrients for survival. This condition is known as 
myocardial ischemia. If the adequate blood is not quickly restored, the surrounding cardiac tissue 
undergoes apoptosis or necrosis. Human cardiomyocytes have a very limited ability to 
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regenerate, thus as the heart begins to remodel after ischemia, the cardiac muscle tissue is 
irreversibly replaced by fibrotic collagen scar tissue. The scar tissue therefore disrupts proper 
contractile function resulting in decreased cardiac performance, ventricular dilation, and wall 
thinning. This process of remodeling continues until the fibrotic scar’s tensile strength balances 
the distending forces of the heart3. The ischemic tissue lacks function during systole, therefore 
unable to contract of contribute to pressure generation associated with the heart. This forces 
other anatomical segments of the heart to overcompensate leading to chronic ischemic 
cardiomyopathy and congestive heart failure. Stem cell therapies have been extensively 
researched in order to promote regeneration of cardiac tissue, but have several challenges such as 
cell homing, retention and appropriate differentiation to cardiac muscle. Nanotechnology is a 
novel approach that may assist in the delivery and tissue retention of stem cells. Despite 
significant advances in the clinical treatment and prevention of AMI, this sort of 
nanotechnology-based stem cell therapy has not yet been performed in vivo and over 370,000 
Americans still die from CAD each year2.  
Before nanotechnology is used in vivo, there is a need to address issues like opsonization, 
phagocytosis by macrophages, and sequestration to the liver and spleen for eventual elimination 
from the body6. Information in this regard would help to determine the gold nanoparticle’s 
longevity in circulation and clearance rate from the body. The fates of these nanoparticles 
depend heavily on their physio-biochemical properties, including their size, shape, and surface 
chemistry. Novel approaches have reported to alter the surface chemistry of nanoparticles to 
obtain desirable functionality allowing for greater blood circulation times as well as increased 
biocompatibility7. 
Since the functionality of nanoparticles in vivo is still under scrutiny, tagging conjugated 
gold nanoparticles with a fluorophore can allow researchers to locate and image these particles 
under ultra violet (UV) light. The fluorophore used in this study, FITC has an excitation 
maximum at 490 nm and an emission maximum at 525 nm with a high quantum yield of 0.9310. 
The quantum yield of a fluorophore is the number of photons emitted per photon absorbed. In 
other words it is a measure of efficiency 0.0 being completely inefficient and 1.0 being 
maximally efficient. Greater quantum yields are more desirable as they are stronger fluorescents 
and are easier to image using fluorescent imaging techniques. 
The objective of this study is to conjugate citrate gold nanoparticles with a fluorescent 
antibody, FITC-IgG, and show successful conjugation and fluorescence. Successful completion 
of this will allow further applications of stem cell therapy for treatment of myocardial infarctions 
through nanotechnology. 
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Materials and Methods 
Preparation of Citrate Au Nanoparticles: 
15 nm diameter Au particles were prepared by citrate reduction of HAuCl4. Images were 
then captured using a Transmission electron microscope (TEM) to observe the nanoparticles and 
determine the size and dispersity. TEM image is shown in Figure 3. 
 
Figure 3 TEM image of citrate Au nanoparticles. 
 
A spectrophotometer was used to measure the absorbance of the gold nanoparticles are 
various wavelengths to confirm particle identity. 1mL of the citrate gold solution (0.1mg/mL) 
was centrifuged at 11,000 revolutions per minute (RPM) for 15 minutes. The supernatant was 
removed and 100 µL of K-PBS was added. This tube was labeled A. The optical density was 
obtained of tube A.  The absorbance spectrum is shown in Figure 4. 
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Figure 4. The absorbance spectrum of citrate gold nanoparticles shows an emission peak at 519nm. 
 
Conjugation of Au Nanoparticles with FITC-IgG: 
  40 µL of FITC-IgG was added to 60 µL of K-PBS and was labeled B. The absorbance 
spectrum of tube B was obtained and images of tube B under UV light was captured. The 
fluorescence of tube A and tube B were measured with the fluorospectrometer and is shown in 
Figure 7. The 1 mL contents of tube B was added dropwise into tube A while it was vortexed. 
This solution contained both the Au nanoparticles and the FITC-IgG molecules and was labeled 
tube C. The mixture was incubated at room temperature without shaking for 10 minutes. The 
contents of tube C were placed in the fluorospectrometer to obtain its fluorescence spectra. 
Images of tube C were taken next to tube A under UV light.  
Washing of Unreacted Molecules: 
The mixture was then centrifuged at 11,000 RPM for 15 minutes. The supernatant was 
then removed and the optical density of the supernatant solution was measured using the 
spectrophotometer. 1 mL of potassium phosphate-buffered saline (K-PBS) containing bovine 
serum albumin (BSA) was added and mixed. This mixture was centrifuged at 11,000 RPM for 15 
minutes and the supernatant was removed. Another 1 mL of K-PBS containing BSA was added 
and then centrifuged at 11,000 RPM for 15 minutes removing the resulting supernatant. 200 µL 
of K-PBS (pH 8.2, 2mM) was added to the tube and mixed. The optical density and fluorescence 
of this resulting solution was measured. 
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Calculations 
The optical density of the supernatant unreacted mixture of FITC-IgG and AuNPs was measured 
and subtracted from the optical density of FITC-IgG alone. 
0.624 − 0.227 = 0.397 
 This gives the optical density of bound FITC-IgG molecules which proportionally corresponds 
to a mass. The mass of FITC-IgG alone was 0.06mg. So the mass of bound FITC-IgG is 
proportional based on the absorbance. 
0.624
0.397
=  
0.06 𝑚𝑔
𝑥
 
x = 0.03817 mg bound FITC-IgG 
The mass can be converted to a number of moles using the molecular weight of IgG, 150 kg.  
0.03817 𝑚𝑔
1
∗
1 𝑔
1000 𝑚𝑔
∗
1 𝑘𝑔
1000 𝑔
1 𝑚𝑜𝑙 𝐼𝑔𝐺
150 𝑘𝑔
= 2.5467 ∗ 10−10 𝑚𝑜𝑙 𝐼𝑔𝐺 
The number of moles can then be converted to a number of particles using Avogadro’s number. 
2.5467 ∗ 10−10 𝑚𝑜𝑙 𝐼𝑔𝐺
1
∗
6.023 ∗ 1023 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
1 𝑚𝑜𝑙
= 1.5339 ∗ 1014 𝐼𝑔𝐺 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠 
The ratio of FITC-IgG particles to the number of AuNPs particles in solution, gives an 
approximation of FITC-IgG molecules bound per nanoparticle. 
1.5339 ∗ 1014 𝐼𝑔𝐺 𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠
6.37 ∗  1012 𝐴𝑢𝑁𝑃𝑠 
≈ 𝟐𝟒 𝑰𝒈𝑮 𝒎𝒐𝒍𝒆𝒄𝒖𝒍𝒆𝒔 𝒃𝒐𝒖𝒏𝒅 𝒑𝒆𝒓 𝑨𝒖𝑵𝑷 
There are approximately 24 FITC-IgG molecules bound per AuNP. 
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Results 
The absorbance spectrum of the citrate-AuNPs was compared to the FITC-IgG 
conjugated citrate-AuNPs and is shown in Figure 5. A noticeable red-shift was detected once the 
antibodies were bound to the nanoparticles. There was also a slight broadening of the extinction 
peak.  
 
Figure 5 Spectrophotometer: After FITC-IgG conjugation of AuNPs, a slight red-shift was observed and a noticeable 
broadening of the absorbance peak. This is an indication of successful conjugation. Absorbance increased at 280nm 
indicating the presence of proteins. 
In addition, the line for the conjugated AuNPs showed an absorbance peak at 280 nm, which is 
the same wavelength at which proteins have peak absorbance15. 
 Images of FITC-IgG, unwashed conjugated AuNPs, and washed conjugated AuNPs were 
captured under UV light and were compared in Figure 6. Image A, showed a very strong 
fluorescence. Image B still showed a strong fluorescence but quenched. After washing away 
unreacted molecules from the tube from image B the fluorescence was further reduced.  
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A    B    C 
   
Figure 6 UV Light: Image A compares fluorescence of AuNPs to FITC-IgG. Image B compares AuNPs to FITC-IgG + AuNPs. 
Image C compares AuNPs to conjugated AuNPs. 
 
A comparison of the relative fluorescence for the AuNPs, FITC-IgG, and the unwashed 
reaction mixture is shown in Figure 7. This data is consistent with the UV light images from 
Figure 6. Once the nanoparticles are mixed with the fluorescent antibodies, the magnitude of the 
fluorescence decreased almost six-fold.  
 
Figure 7 Fluorospectrometer: Relative fluorescence measurements were obtained for each substrate and product. 
Fluorescence was quenched for the reaction mixture. 
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After washing the mixture, the fluorescence spectrum in Figure 8 showed further 
quenching of the fluorescence. However, a fluorescence signal still exists.  
 
Figure 8 Fluorescence is further reduced after washing unreacted molecules 
 
The BIO-RAD Gel Doc system was used to conduct a fluorescence test comparing the signal 
from the citrate-AuNPs mixture and the conjugated FITC-IgG AuNPs. Figure 9 below compares 
the image of the slide before and after placing it into the Gel Doc system. A signal containing no 
fluorescence will show no color and a signal containing fluorescence will show up white. The 
images in Figure 9 outline a faint fluorescent signal from the conjugated nanoparticle. This 
information is consistent with the fluorospectrometer readings. 
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Figure 9 Dot Test: Using the BIO-RAD Gel Doc system, a fluorescent detection test was conducted to 
further investigate fluorescent properties of the conjugated AuNPs. (A) Citrate AuNPs control, (B) 
Conjugated AuNPs. 
 
To complete our data acquisition, images were taken using a Leica Confocal Microscope SP5II. 
The advantage of using a laser scanning confocal microscope is reduced blurriness of images due 
to light scattering, increased resolution and an improved signal-to-noise ratio through the use of a 
pinhole at the confocal plane of the lens that serves to eliminate out of focus light16. For the 
image shown in Figure 10 four laser wavelengths were used for excitation at a power level of 
approximately 5%; 488 nm, 496 nm, 514 nm, 633 nm. The maximum emission wavelength range 
for FITC is 520 nm to 530 nm12. The confocal images showed a significant number of small 
particles that fluoresced with some being larger and stronger than others.  
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Figure 10 Confocal Microscopy: The confocal image of the final conjugated product indisputably revealed several fluorescent 
nanoparticles to conclude the investigation. 
 
Discussion & Future Directions 
The spectrophotometer readings in Figure 5 were an indication of molecule adsorption to 
the surface of the AuNPs due to a change in refractive index of the surrounding solution9. There 
was also a slight broadening of the extinction peak which occurs with particles of greater size. 
Since proteins generally have the greatest absorbance at 280 nm, we can conclude that the 
conjugated particles contained antibodies. The fluorospectrometer readings in Figure 7 showed 
us that the addition of the fluorescent antibodies to the AuNPs solution is reducing the 
fluorescence to one that is in between that of the two individual components. Furthermore, 
assuming all unreacted FITC-IgG molecules were removed, the signal of the unwashed mixture 
from Figure 8 may have been from the free flowing FITC-IgG. Thus, the washed mixture 
showed a signal characteristic of the conjugated nanoparticles only. This must mean that the sole 
binding of the FITC-IgG to the AuNPs is resulting in a quenched fluorescence of the 
14 
 
fluorophore.It may be possible that unreacted FITC-IgG molecules remained in solution after 
being washed.  We would expect these molecules to fluoresce equally. The confocal microscope 
image in Figure 10 shows some stronger than others which may allow us to be certain to some 
degree that the lower intensity fluorescent particles are those that are conjugated to the gold 
nanoparticles and thus quenched.  
The spectrophotometer readings were strong indications that conjugation of gold 
nanoparticles with the fluorescent antibodies was successful. However, a significant amount of 
quenching of the fluorescence was evident from the various fluorescence detection tests. 
Fluorescence can be quenched due to the nanoparticle’s plasmon field strength. As the distance 
of the fluorescent agent increases from the nanoparticle’s surface, the field strength decreases 
and the effects of quenching are significantly reduced13. To combat this issue a linker molecule 
could be used to extend the fluorescent antibody away from the nanoparticle. This would allow 
for the plasmon field strength to have a lesser electronic impact on the quenching of the 
fluorescence. Other studies have suggested that having the nanoparticle’s absorbance peak in the 
same region as the fluorophore’s emission peak could impact the ability for the fluorophore to be 
fully expressed.  
In this particular study, the directionality of the antibodies was not controlled; therefore 
further imaging is required to confirm that the constant region was bound directly to the 
nanoparticles14. For stem cell therapy to applicable the variable region to the antibody must be 
exposed to attract and bind specific antigens. In addition, controlling the directionality of the 
bound antibodies will allow scientists to predict how close the fluorophore is to the nanoparticle 
surface and thus predicting the amount of fluorescent quenching. 
The mechanisms used in this study involved non-covalent binding. Other methods of 
binding could be employed for increased stability and directional orientation such as covalent 
bonds involving free sulfhydryl groups14.  
In conclusion, gold nanoparticles were successfully conjugated with fluorescent 
antibodies, and the methodology for a subsequent stem cell study was developed and validated. 
The ease of detection of nanoparticles is extremely important as we consider an in vivo study, 
and thus quenching must be minimized. Prior to proceeding to experiments with stem cells, we 
plan to test the utilization of a linker molecule, control the directionality of the antibodies, and 
explore covalent bonding to improve nanoparticle fluorescence. 
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